A comparative study between two different types of ureteric stents in terms of stent related symptoms and complications

A Randomized Study Comparing Dalela Triple-J and Conventional Double-J Ureteral Stents in Terms of Stent-Related Symptoms and Complications - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108002

Enrollment

210

Registered

2026-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: Dalela Triple J Ureteric Stent: Dalela Triple J Ureteric Stent is a type of ureteric stent with some design modifications. It has an extra loop at lower end to prevent stent related low

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 years and above undergoing elective endourological procedures (URSL, RIRS, stented ESWL) requiring temporary ureteral stenting. 2.Patients are able and willing to complete USSQ questionnaires at specified follow-up intervals.

Exclusion criteria

Exclusion criteria: 1.Active urinary tract infection at the time of stent insertion. 2.Known ureteral strictures, congenital anomalies, or previous ureteric surgery on the same side. 3.Pregnancy or lactation. 4.Patients with small capacity bladder. 5.Patients with overactive bladder. 6.Patients with genitourinary tuberculosis. 7.Known allergy or contraindication to stent material. 8.Patients requiring bilateral stents or long term indwelling stents more than 6 weeks. 9.Patients requiring emergency stenting for obstructive uropathy or malignancy. 10.Patients who are not willing to participate in the study

Design outcomes

Primary

Measure	Time frame
Ureteric Stent Symptoms Questionnaire include: 1.urinary symptoms, 2.body pain, 3.general health, 4.work performance, 5.sexual function, 6.additional problems.Timepoint: 3-4 weeks postoperatively when patient comes for stent removal.	—

Secondary

Measure	Time frame
Secondary Outcome Assessment: Complications: Hematuria, urinary tract infection, stent migration, or need for early removal. Documented at the day of stent removal. Analgesic and pharmacologic requirements: Record type, dosage, and duration of medications used to relieve stent-related discomfort. Patient satisfaction: Assessed at stent removal via a 5-point Likert scale (very dissatisfied , very satisfied). Timepoint: 3-4 weeks post op	—

Measure

Time frame

Secondary Outcome Assessment: Complications: Hematuria, urinary tract infection, stent migration, or need for early removal. Documented at the day of stent removal. Analgesic and pharmacologic requirements: Record type, dosage, and duration of medications used to relieve stent-related discomfort. Patient satisfaction: Assessed at stent removal via a 5-point Likert scale (very dissatisfied , very satisfied). Timepoint: 3-4 weeks post op

—

Countries

India

Contacts

Public ContactDr Sandeep Beniwal

JIPMER , Puducherry

dr.rudraghorai@gmail.com9874230282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026